Clinical trial
Treatment of Patients With Cancer With Genetically Modified Salmonella…
NCT00004988 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004988 |
|---|---|
| Title | Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria |
| Official title | A Phase I Trial of a Live, Genetically Modified Salmonella Typhimurium (VNP20009) for the Treatment of Cancer by Intravenous Administration |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer, Neoplasm, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | VNP20009 |
| Enrollment | 45 |
| Start date | Mar 1, 2000 |
| Completion | Oct 1, 2002 |
| First posted | Mar 20, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: